Abstract In recent years, the click reaction has found rapidly growing applications in the field of radiochemistry, ranging from a practical labeling method to molecular imaging of biomacromolecules. This present review details the development of highly reliable, powerful and selective click chemistry reactions for the rapid synthesis of new radiotracers for molecular imaging.
Introduction
Molecular imaging aims to noninvasively visualize, characterize and quantify biological processes at the cellular and molecular levels in vivo. Current biomedical science is rapidly adapting molecular imaging techniques to reveal the molecular processes of disease in living subjects. To this end, nuclear imaging, magnetic resonance imaging and near-infrared fluorescence imaging are emerging as key imaging modalities.
Nuclear imaging techniques are based on the radiolabeling of specific molecular probes using decaying radioisotopes. In biologically active probes, the emitted radiation can be detected by performing either positron emission tomography (PET) or single-photon computed tomography (SPECT) [1] . Both methods can provide insights into the specific biochemical processes of molecular probes and the pathophysiology of disease. Usually, the synthetic preparation of suitable radiolabeled probes has been developed and optimized using radiochemistry techniques. For the synthesis of novel radiotracers ranging from small organic and bioactive molecules to highmolecular-weight compounds such as peptides, proteins or oligonucleotides, most of the radiolabeling strategies focus on the radioactive prosthetic groups, which allow an effective and bioorthogonal conjugation reaction between bioactive molecules and radiolabeled building blocks.
Cu(I)-catalyzed formation of 1,2,3-triazole by Huisgen's [2+3] cycloaddition of terminal alkynes and azides, commonly called Bclick chemistry,^was first described by Kolb et al. in 2001 [2] . The formation of 1,4-disubstituted 1,2,3-triazole is a particularly powerful ligation method with comparably favorable properties, including high and reproducible yields under mild aqueous conditions. Following the basic concepts of click chemistry, radiochemistry exploits the special advantages of this class of reactions for the introduction of radionuclides in small molecules as well as biomacromolecules. The present review addresses the recent applications of click chemistry reactions to the radiolabeling of biomolecules in the field of molecular imaging.
Copper Catalyzed Azide-Alkyne Cycloaddition (CuAAC) Cu(Ι)-catalyzed azide-alkyne cycloaddtion has become a useful tool in various fields of organic synthesis. Notably, this reaction has been rapidly applied in radiochemical procedures for the introduction of radioisotopes in small molecules as well as peptides. Figure 1 summarizes the diverse approaches to the synthesis of radiotracers using various 18 F-labeled prosthetic groups. In 2006, Marik and Sutcliffe first described the preparation of 18 F-labeled peptides using the CuAAC reaction. The Cu(I)-mediated cycloaddition reaction between [ 18 F]fluoroalkynes (Fig. 1a) and various peptides produced 18 F-labeled peptides in quantitative radiochemical yields (RCY, 54-99 %) and high purities [3] . Moreover, 18 F-CuAAC offers a short radiolabeling time under mild conditions. Thus, 18 F-CuAAC is a very attractive strategy for the design and synthesis of radiotracers for molecular imaging purposes. Ross and coworkers used 6-[
18 F]fluoro-1-hexyne to generate, by click reaction, a folic acid derivative as a promising target molecule in oncology [4] . 18 F-click folate was synthesized by a convenient and efficient two-step radiosynthesis. For a more flexible 18 F-labeled PEGylated alkyne (Fig. 1c) shows suitable advantages for in vivo studies because of a longer circulation time and an enhanced blood clearance [16] . In terms of radiolabeling, the corresponding 18 F-labeled PEGylated alkyne and azide are thermally stable and nearly nonvolatile at the reaction temperature under ambient pressure required by the one-pot, two-step synthetic Fig. 1f ), for the efficient labeling of cRGDfK and a D4 peptide [21] .
In another approach, the Thonon group introduced an 18 Flabeled aryl azide, namely, 1-(azidomethyl)-4-[
18 F]-fluorobenzene ( Fig. 1g) , which was used to label the 4-ethynyl-L-phenylalanine-containing peptide via click reaction [22] . The desired 18 F-labeled peptide was prepared in quantitative RCY within 15 min. The same group reported that 1-(azidomethyl)-4-[ 18 F]-fluorobenzene can also be used to label a double-stranded oligonucleotide (siRNA) in 15±5 % of RCYs [23] . In order to enhance the in vivo behavior of the targeted macromolecules, such as blood clearance and stability, an [ 18 F]fluorodeoxyglycosyl azide was designed and developed by Schibli's group in 2012 [24] .
The reaction between the 18 F-labeled 2-deoxy-2-fluoroglucopyranosyl azide ( (Fig. 3) . Through their favorable biodistribution and in vivo tissue clearance, a click reactionbased glycopeptide method would provide useful viable alternative radiotracers for PET imaging. Fig. 1j ), with beneficial properties such as high hydrophilicity and medium molar mass, were developed by Pretze and Mamat [26] . Both show advantageous properties such as desriable logP/D, solubility and in vitro stability. In addition, because spiro compounds allow a convenient separation using silica gel cartridges, the corresponding automated synthesis based on the CuAAC reaction is available.
Unlike previous studies, Mindt et al. developed an application of the Cu-catalyzed cycloaddition reaction for radiometal chemistry [27] . They described a click-to-chelate methodology that allows the successful labeling of peptides with 99m Tc(CO) 3 generating click-based constructs with improved in vivo stability (Fig. 4) [28] .
Copper-Free Azide-Alkyne Cycloaddition
The CuAAC reaction is one of the most attractive synthetic routes; however, the obvious limitation of this method is the cytotoxicity of copper. Because of safety concerns regarding the contamination of radiolabeled compounds with traces of copper, the CuAAC reaction is not suitable for the development of in vivo pretargeting methodologies.
In recent years, the Bertozzi group pioneered the copperfree click (CFC) reaction, which was referred to as strainpromoted azide-alkyne cycloaddition (SPAAC) [29] . Numerous research groups have employed this reaction for the incorporating of radioisotopes into biomolecules. In 2011, Bouvet et al. described the copper-free click reaction for 18 F-labeled azadibenzocyclooctyne (ADIBO) and azides such as 4-azidoaniline, 6-azido-6-deoxyglucose and azidogeldanamycin (Table 1, entry 1) . The SPAAC reaction, carried out in different solvents in the presence of low concentrations of various azides, affords the desired product in good yields, can be used to label molecules or peptides with fluorine-18 and has great potential for in vivo pretargeting applications [30] . 18 F]FBA-C6-ADIBO-based prosthetic group was reported to not interfere with the α v β 6 -binding in in vitro experiments, but was found to affect the pharmacokinetics because of its size and lipophilic nature. In view of the undesirable in vivo results, the cyclooctyne moiety should be modified to focus particularly on rapid chemical techniques and in vivo compatibility.
In 2011, the Feringa group reported the rapid radiolabeling of bombesin with fluorine-18 by using the SPAAC reaction [34] . This straightforward protocol was performed by simple stirring of various 18 F-labeled azides and the modified bombesin analog for 10-15 min at room temperature (Table 1, entry 5). As a result, 18 F-labeled bombesin peptides with different properties are readily accessible from the same modified bombesin peptide, thus allowing for rapid modification and fine-tuning. In addition, the optimal lipophilicity for the target binding site and metabolic in vivo clearance can be achieved.
The Carroll group demonstrated, through in vitro stability measurements and small animal PET images of a BALB/c nude mouse, that 2-[ 18 F]fluoroethylazide is advantageous for pretargeting with a SPAAC reagent [35] . In addition, they optimized the SPAAC reaction with various cyclooctynes and proposed that these reactions represent an attractive strategy for application-specific tuning in pretargeting systems ( The Kim group developed a labeling protocol based on the SPAAC reaction followed by a chemo-orthogonal purification reaction with an azide-bound resin [36] . This process provides a rapid and selective isolation method without the need for HPLC purification and formulation (Table 1 , entry 7). Using this simple solid-phase extraction with the azide-bound resin, called ADIBO scavenger resin, 18 F-labeled ADIBOT (azadibenzocyclooctatriazole) RGD dimer peptide was successfully synthesized in high RCY via the SPAAC reaction between 18 F-labeled PEG-azide and RGD-ADIBO peptide without HPLC purification in high RCY [37] . 
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Diels-Alder Cycloaddition
Although the SPAAC reaction in the presence of ADIBO eliminates the risk of cytotoxic copper in the final formulation, the hydrophobicity and the relatively slow in vivo compatibility of ADIBO can be problematic for pretargeting systems [38, 39] . Recently, a new click ligation, i.e., the inverse electron demand [4+2] Diels-Alder (IEDDA) cycloaddition between a 1,2,4,5-tetrazine and strained alkene dienophile, was reported as an alternative SPAAC reaction [40] . The IEDDA reaction is selective, high-yielding, clean, biocompatible and bioorthogonal. In 2011, Li et al. reported the first application of the IEDDA ligation in radiochemistry using an 18 F-labeled trans-cyclooctene ( 18 F-TCO) [41] . The synthesis of 18 F-TCO was performed under relatively mild radiolabeling conditions to afford the desired product in yields of up to~70 %; next a rapid, selective, and clean IEDDA ligation was performed without the need for any catalyst ( Table 2 , entry 1).
The Reiner group reported the IEDDA reaction between TCO and tetrazine for the preparation of 18 F-AZD2281, a poly-ADP-ribose-polymerase1 (PARP1) PET imaging agent ( Table 2 , entry 2) [42] . In this work, in order to avoid lengthy HPLC purifications, TCP-decorated scavenger beads (4 mol equiv. of TCO) were used to remove unreacted AZD2281-tetrazine. Subsequent magnetic removal of the beads provided 18 F-AZD2281 in high RCY (92±0.4 %). This TCO/terazine IEDDA reaction has several advantages such as extremely fast kinetics at room temperature, independency of catalysts and high selectivity. In addition, the IEDDA-derived small-molecule imaging agent, 18 F-AZD2281, was shown to effectively target PARP1 expression in vivo in murine models of ovarian and pancreatic cancer.
In a similar approach, Sevaraj et al. reported an IEDDAgenerated 18 F-labeled RGD peptide [43] . The modified RGD precursor containing 3,6-di-(2-pyridyl)-s-tetrazine was used for IEDDA ligation (Table 2 , entry 3). The resulting 18 F-RGD peptide proved to be effective for the imaging of integrin α v β 3 expression in in vivo models.
As an extended application of IEDDA click reactions in radiochemistry, Liu et al. reported an efficient method for the 18 F-labeling of cysteine containing peptides and proteins based on the click reaction with tetrazinyl-maleimide and subsequent 18 F-labeling through terazine-trans-cyclooctene ligation (Table 2 , entry 4) [44] . 18 F-labeled RGD peptide and VEGF protein were obtained within 5 min in 95 and 75 % RCY, respectively. Moreover, Wu's group used 18 F-tetrazine trans-cycloctene (TTCO) ligation for the development of an 18 F-labeled exendin-4 targeting the glucagonlike peptide-1 receptor (GLP-1R) ( Table 2 , entry 5). The resulting 18 F-TTCO-Cys 40 -exendin-4 shows specific binding to GLP-1R and provides a method to noninvasively image transplanted islets through small animal PET studies [45] . With the aim to increase the in vivo stability of the (Table 2 , entry 7). Although this methodology underlines the disadvantage of the short half-life of carbon-11, the first 11 C-labeled tetrazine was successfully prepared in 33 % RCY and the final click ligation proceeded rapidly (within 20 s) [47] .
In antibody-based PET bioconjugates, positron-emitting radiometals (e.g., 64 Cu, 86 Y, and 89 Zr) offer significant advantages such as high image quality, desirable radioactive halflives and a simple radiolabeling method. In 2011, the Lewis group reported the use of the IEDDA reaction for the synthesis of PET radiometal-based agents [48] . In this work, the antibody trastuzumab was first covalently coupled to norbornene and then reacted with tetrazines bearing the chelators 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid (DOTA) or desferrioxamine (DFO) and subsequently radiometalated with Zrtrastuzumab proved to be nearly identical in terms of the stability (>96 %), number of chelates per antibody (2.2±0.3 for DOTA/mAb and 2.3±0.4 for DFO/mAb), high specific activity (>2.9 mCi/mg) and in vitro immunoreactivity (>93 % in all cases). In vivo PET images revealed significant, selective and specific uptake of 64 Cu-and 89 Zr-trastuzumab in HER2-positive BT-474 xenografts.
Application of the Click Reaction to Pretargeting Strategies
Because of its very fast kinetics, the IEDDA reaction holds promise as an ideal methodology for in vivo pretargeting applications. To this end, pretargeted imaging and therapy were designed to avoid the high radiation exposure due to the slow pharmacokinetics of radioimmunoconjugates and high background doses by decoupling the targeting vector from the radioisotope at the time of injection.
The pretargeting approach consists of two steps. First, target-specific molecules or immunoconjugates are injected and bind to the target site. Next, radiolabeled compounds are added, which selectively conjugate with the pretreated molecules on the target site. This method presents several advantages, including superior image contrast, possible use of shortlived PET radionuclides and a decrease in the radiation doses to the nontarget [49] . Therefore, the pretargeting imaging and therapy require a rapid and accurate chemical reaction in in vivo models.
In 2010, Rossin et al. reported a tumor pretargeting strategy using the IEEDA reaction between a TCOmodified mAb and radiolabeled tetrazine [50] . In this work, an axially linked TCO-oxymethylbenzamide tagged CC49 antibody and 111 In-labeled tetrazine were used (Table 3, entry 1).
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In-labeled tetrazine was injected 24 h after the treatment with CC49-TCO (100 μg). This system reduced the amount of free circulating CC49-TCO, while significantly increasing the tumor-to-nontumor ratios in tumorbearing mice. Robillard's group described a pretargeted radioimmunotherapy using the IEEDA reaction between a 177 Lu-labeled tetrazine probe and TCO-tagged antibody, F-labeled tetrazine with fast and reliable pharmacokinetics [52] . In this work, the water-soluble 18 F-labeled tetrazine proved to be suitable for bioothogonal PET imaging and in vivo detection of dienophile-tagged molecules (Table 3 , entry 2). With the aim of developing a predictable method for efficient in vivo click reactions, Devaraj et al. designed pharmacokinetically optimized reactants, namely polymer-modified tetrazines (PMT) with dextran scaffolds, which proved to be a key enabler for pretargeting imaging [53] . Using fluorescent PMT for cellular resolution and 18 F-labeled PMT for in vivo imaging combining TCO-anti-CD45 monoclonal antibodies, cancer cell epitopes were easily conjugated in vivo (Table 3 , entry 3).
The Lewis group reported a methodology for pretargeted PET imaging based on the bioorthogonal IEEDA reaction between the TCO-modified huA33 antibody and a 64 Cu-labeled NOTA-modified tetrazine (Table 3 , entry 4) [54] .
In in vivo experiments, SW1222 xenografts were injected with TCO-huA33 and accumulation of the antibody in the tumor was allowed over 24 h. Subsequently, mice were injected with the 64 Cu-labeled NOTA-modified tetrazine. Interestingly, although huA33 directly labeled with either 64 Cu or 89 Zr showned higher tumor uptake than the pretargeted huA33, the pretargeting system yielded comparable images and significantly enhanced tumor-to-muscle ratios.
Using 68 Ga-labeled cetuximab, pretargeted EGFR PET imaging was performed by the Aboagye group in 2014 [55] . The Devaraj group also reported 68 Ga chelating bioorthogonal tetrazine polymers for the IEDDA reaction with pretargeted TCO-A33 antibody [56] .
In summary, the present review details the current attempts in the development of highly reliable, selective and rapid ligation methodologies for the synthesis of radiotracers through click chemistry reactions. Their application to in vivo imaging and therapy was reported to be very effective and allow the potential use of radiotracers in pretargeting strategies. Thus, the click reaction is expected to serve as a convenient radiolabeling methodology and a point of entry for a wide range of molecular imaging techniques.
